Reduced GABA uptake sites in the temporal lobe in schizophrenia - PubMed (original) (raw)
Reduced GABA uptake sites in the temporal lobe in schizophrenia
M D Simpson et al. Neurosci Lett. 1989.
Abstract
The binding of [3H]nipecotic acid, a ligand for labelling GABA uptake sites in brain, was measured in left and right frontal cortex, polar temporal cortex, hippocampus and amygdala from control and schizophrenic postmortem brains. In schizophrenic brains, single concentration [3H]nipecotic acid binding was reduced bilaterally in amygdala and hippocampus and on the left side only in polar temporal cortex. These data suggest that GABA neurones are involved in the cerebral atrophy of schizophrenia and, in agreement with other studies, that this process is most pronounced in left temporal cortex.
Similar articles
- Comparison of glutamate and gamma-aminobutyric acid uptake binding sites in frontal and temporal lobes in schizophrenia.
Simpson MD, Slater P, Deakin JF. Simpson MD, et al. Biol Psychiatry. 1998 Sep 15;44(6):423-7. doi: 10.1016/s0006-3223(98)00077-8. Biol Psychiatry. 1998. PMID: 9777172 - Deficit and hemispheric asymmetry of GABA uptake sites in the hippocampus in schizophrenia.
Reynolds GP, Czudek C, Andrews HB. Reynolds GP, et al. Biol Psychiatry. 1990 May 1;27(9):1038-44. doi: 10.1016/0006-3223(90)90039-5. Biol Psychiatry. 1990. PMID: 2159350 - Loss of cortical GABA uptake sites in Alzheimer's disease.
Simpson MD, Cross AJ, Slater P, Deakin JF. Simpson MD, et al. J Neural Transm. 1988;71(3):219-26. doi: 10.1007/BF01245715. J Neural Transm. 1988. PMID: 2833574 - Abnormal neurochemical asymmetry in the temporal lobe of schizophrenia.
Shirakawa O, Kitamura N, Lin XH, Hashimoto T, Maeda K. Shirakawa O, et al. Prog Neuropsychopharmacol Biol Psychiatry. 2001 May;25(4):867-77. doi: 10.1016/s0278-5846(01)00149-x. Prog Neuropsychopharmacol Biol Psychiatry. 2001. PMID: 11383982 Review. - Pathogenesis of schizophrenia: Part II. Temporo-frontal two-step hypothesis.
Kurachi M. Kurachi M. Psychiatry Clin Neurosci. 2003 Feb;57(1):9-15. doi: 10.1046/j.1440-1819.2003.01073.x. Psychiatry Clin Neurosci. 2003. PMID: 12519449 Review.
Cited by
- System biology approaches to identify hub genes linked with ECM organization and inflammatory signaling pathways in schizophrenia pathogenesis.
Bhuiyan P, Sun Z, Khan MA, Hossain MA, Rahman MH, Qian Y. Bhuiyan P, et al. Heliyon. 2024 Jan 26;10(3):e25191. doi: 10.1016/j.heliyon.2024.e25191. eCollection 2024 Feb 15. Heliyon. 2024. PMID: 38322840 Free PMC article. - Searching for unique endophenotypes for schizophrenia and bipolar disorder within neural circuits and their molecular regulatory mechanisms.
Benes FM. Benes FM. Schizophr Bull. 2007 Jul;33(4):932-6. doi: 10.1093/schbul/sbm064. Epub 2007 Jun 16. Schizophr Bull. 2007. PMID: 17575303 Free PMC article. Review. - Amygdala abnormalities in first-degree relatives of individuals with schizophrenia unmasked by benzodiazepine challenge.
Wolf DH, Satterthwaite TD, Loughead J, Pinkham A, Overton E, Elliott MA, Dent GW, Smith MA, Gur RC, Gur RE. Wolf DH, et al. Psychopharmacology (Berl). 2011 Dec;218(3):503-12. doi: 10.1007/s00213-011-2348-7. Epub 2011 May 21. Psychopharmacology (Berl). 2011. PMID: 21603892 Free PMC article. Clinical Trial. - Cell-based therapies for the treatment of schizophrenia.
Donegan JJ, Lodge DJ. Donegan JJ, et al. Brain Res. 2017 Jan 15;1655:262-269. doi: 10.1016/j.brainres.2016.08.010. Epub 2016 Aug 18. Brain Res. 2017. PMID: 27544423 Free PMC article. Review. - Effect of pre- and post-treatment with Bacopa monnieri (Brahmi) on phencyclidine-induced disruptions in object recognition memory and cerebral calbindin, parvalbumin, and calretinin immunoreactivity in rats.
Piyabhan P, Tingpej P, Duansak N. Piyabhan P, et al. Neuropsychiatr Dis Treat. 2019 May 1;15:1103-1117. doi: 10.2147/NDT.S193222. eCollection 2019. Neuropsychiatr Dis Treat. 2019. PMID: 31118643 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical